Marketing-authorisation holder · Denmark
Bavarian Nordic A/S
33 medicines in 7 countries, as authorisation holder, manufacturer and marketer.
Group structure
Part of
BavarianPharmaceutical groupOther companies in the group
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
1–25 of 33
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| IMVAMUNE50000000 ccid50 / 0.5 ml · Suspension | Modified vaccinia virus | Canada | Authorised | 2015 |
| Imvanex | Smallpox and monkeypox vaccine | EU (EMA) | Authorised | 2013 |
| IMVANEXSospensione iniettabile | Vaccino antivaiolo e antivaiolo delle scimmie | Italy | Authorised | |
| IMVANEX, suspensie voor injectieSuspensie voor injectie | Levend verzwakt niet vermenigvuldigend orthopokkenvirus, stam gemodificeerd chorioallantois vaccinia ankara-bavarian nordic | Netherlands | Authorised | 2013 |
| IMVANEX SUSPENSION INYECTABLE5 x 10e7 unidades infecciosas (Inf.U) · Suspensión inyectable | Virus vivo modificado la viruela vacunoide ankara | Spain | Authorised | 2024 |
| Jynneos0.5-3.95 x 10e8 inf. u/.5ml · For Injection | Smallpox, Mpox vaccine, live, non-replicating | United States | Marketed | 2025 |
| Jynneos0.5-3.95 x 10e8 inf. u/.5ml · Injection | Smallpox, Mpox vaccine, live, non-replicating | United States | Marketed | 2019 |
| JYNNEOS (AUT. D.LGS. 219/2006 ART.5, C.2)Sospensione iniettabile | Smallpox and monkeypox vaccine, live, non-replicating | Italy | Authorised | |
| Rabavert2.5iu · For Injection | Rabies vaccine | United States | Marketed | 1997 |
| RABAVERT2.5 unit / ml · Powder For Solution | Inactivated rabies virus | Canada | Marketed | 2005 |
| RABIPURPolvere e solvente per soluzione iniettabile | Vaccino rabbico uso umano colture cellulari | Italy | Authorised | |
| Rabipur poeder en oplosmiddel voor oplossing voor injectie in een voorgevulde spuitPoeder en oplosmiddel voor oplossing voor injectie | Rabiësvirusantigeen, flury lep, geinactiveerd | Netherlands | Authorised | 2016 |
| RABIPUR POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE EN JERINGA PRECARGADAmayor o igual a 2,5 UI · Polvo y disolvente para solución inyectable en jeringa precargada | Virus rabia inactivado | Spain | Marketed | 2016 |
| Rabipur prašak i otapalo za otopinu za injekciju u napunjenoj štrcaljki, cjepivo protiv bjesnoće, inaktiviranoprašak i otapalo za otopinu za injekciju u napunjenoj štrcaljki | Virus bjesnoće, soj flury lep | Croatia | Marketed | 2021 |
| VAXCHORA2000000000 unit / 2 g · Powder For Suspension | Vibrio cholerae, strain cvd live | Canada | Marketed | 2024 |
| Vaxchora100ml · Suspension | Cholera vaccine, live, oral | United States | Marketed | 2020 |
| Vaxchora100ml · Suspension | Cholera vaccine, live, oral | United States | Marketed | 2016 |
| Vaxchora | Cholera vaccine, live, oral | EU (EMA) | Authorised | 2020 |
| VAXCHORAPolvere effervescente e polvere per sospensione orale | Vaccino anticolerico | Italy | Authorised | |
| Vaxchora50ml · Suspension | Cholera vaccine, live, oral | United States | Marketed | 2020 |
| Vaxchora, bruispoeder en poeder voor orale suspensiePoeder voor orale suspensie | Levend verzwakt v.cholera serotype o1 inaba, stam cvd | Netherlands | Authorised | 2020 |
| VAXCHORA POLVO EFERVESCENTE Y POLVO PARA SUSPENSION ORAL4x10e8 - 2x10e9 CFU/dosis · Polvo efervescente y polvo para suspensión oral | Vibrio cholerae cepa cvd | Spain | Marketed | 2020 |
| VIMKUNYA40 mcg / 0.8 ml · Suspension | Chikungunya virus virus particle | Canada | Authorised | |
| Vimkunya | Chikungunya vaccine | EU (EMA) | Authorised | 2025 |
| VIMKUNYA40ug/0.8ml · Injection | Chikungunya vaccine, recombinant | United States | Marketed | 2025 |



